Form 4: Myriad Genetics Chief Accounting Officer Reports Stock Transaction
SEC Form 4 Filing
Natalie Munk, Chief Accounting Officer of Myriad Genetics, reports the disposal of 964 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On September 21, 2024, Natalie Munk, the Chief Accounting Officer of Myriad Genetics Inc., reported a transaction involving the disposal of 964 shares of common stock.
- The shares were disposed of to satisfy tax withholding obligations related to the vesting of restricted stock units.
- The price per share was $27.64.
- Following the transaction, Munk directly owns 43,259 shares of Myriad Genetics Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't indicate a significant change in the company's financial health or management's confidence.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company officers and directors. This transaction is related to tax obligations from vested stock, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | Date used to determine the closing price of Myriad common stock for tax withholding. |
| 09/21/2024 | Date of the stock transaction (disposal of shares). |
| 09/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.